We are live on ! Find out more
AB

Amalgamated Bank Portfolio holdings

AUM $14.5B
1-Year Est. Return 44.3%
This Fund
S&P 500
This Quarter Est. Return
-3.12%
1 Year Est. Return
+44.3%
3 Year Est. Return
+131.76%
5 Year Est. Return
+175.18%
10 Year Est. Return
+715.35%
AUM
$11.7B
AUM Growth
-$497M
Cap. Flow
+$140M
Cap. Flow %
1.2%
Top 10 Hldgs %
29.42%
Holding
2,998
New
11
Increased
1,192
Reduced
1,043
Closed
27

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$19.6M
2
MSFT icon
Microsoft
MSFT
+$13.8M
3
NVDA icon
NVIDIA
NVDA
+$13.7M
4
AMZN icon
Amazon
AMZN
+$10.7M
5
DASH icon
DoorDash
DASH
+$9.22M

Sector Composition

Rank Sector Weight
1 Technology 28.8%
2 Financials 14.49%
3 Consumer Discretionary 11.03%
4 Healthcare 10.88%
5 Industrials 9.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TLYS icon
2876
Tilly's
TLYS
$114M
$2K ﹤0.01%
789
TNGX icon
2877
Tango Therapeutics
TNGX
$4.21B
$2K ﹤0.01%
1,618
TTEC icon
2878
TTEC Holdings
TTEC
$124M
$2K ﹤0.01%
660
TUSK icon
2879
Mammoth Energy Services
TUSK
$122M
$2K ﹤0.01%
785
ULBI icon
2880
Ultralife
ULBI
$88.3M
$2K ﹤0.01%
348
VERU icon
2881
Veru
VERU
$35.5M
$2K ﹤0.01%
457
VRA icon
2882
Vera Bradley
VRA
$98.7M
$2K ﹤0.01%
885
VTYX
2883
DELISTED
Ventyx Biosciences
VTYX
$2K ﹤0.01%
1,594
XBIT icon
2884
XBiotech
XBIT
$68.6M
$2K ﹤0.01%
640
ZURA icon
2885
Zura Bio
ZURA
$504M
$2K ﹤0.01%
1,703
+1,447
+565% +$2.28K
ZYXI
2886
DELISTED
Zynex
ZYXI
$2K ﹤0.01%
745
ANRO icon
2887
Alto Neuroscience
ANRO
$1.04B
$2K ﹤0.01%
737
+430
+140% +$1.54K
TELO icon
2888
Telomir Pharmaceuticals
TELO
$83.2M
$2K ﹤0.01%
667
+501
+302% +$2.19K
BIOA
2889
BioAge Labs
BIOA
$986M
$2K ﹤0.01%
414
AVR
2890
Anteris Technologies
AVR
$769M
$2K ﹤0.01%
+518
New +$3.33K
RHLD
2891
Resolute Holdings Management
RHLD
$1.05B
$2K ﹤0.01%
+70
New +$2.48K
VCSA
2892
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
$2K ﹤0.01%
324
ACRV icon
2893
Acrivon Therapeutics
ACRV
$61.2M
$1K ﹤0.01%
378
AGEN
2894
Agenus
AGEN
$276M
$1K ﹤0.01%
675
AIRS icon
2895
AirSculpt Technologies
AIRS
$308M
$1K ﹤0.01%
227
AKYA
2896
DELISTED
Akoya BioSciences
AKYA
$1K ﹤0.01%
465
ALXO icon
2897
ALX Oncology
ALXO
$262M
$1K ﹤0.01%
897
ARL icon
2898
American Realty Investors
ARL
$237M
$1K ﹤0.01%
54
ATNM icon
2899
Actinium Pharmaceuticals
ATNM
$26.3M
$1K ﹤0.01%
877
JBIO
2900
Jade Biosciences
JBIO
$1.18B
$1K ﹤0.01%
10

Similar funds

Amalgamated Bank's Q1 2025 Portfolio in Review

As of Q1 2025, Amalgamated Bank held 2,998 positions worth $11.7B, down 4.1% from $12.2B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Trading was light in Q1 2025: portfolio turnover was 1.3%. Amalgamated Bank opened 11 new positions and exited 27, leaving the 2,998-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 31% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Amalgamated Bank's largest Q1 2025 buy was Sandisk: 35,097 shares worth $1.67M.
  • Amalgamated Bank added most to Apple in Q1 2025, an estimated $19.6M increase.
  • Amalgamated Bank's biggest Q1 2025 reduction was Williams-Sonoma, cutting an estimated $6.99M.
  • Amalgamated Bank fully exited Aspen Technology Inc in Q1 2025, selling an estimated $3.17M.
  • Amalgamated Bank's ten largest holdings make up 29% of its $11.7B portfolio in Q1 2025.
  • Amalgamated Bank opened 11 new positions and closed 27 in Q1 2025.
  • Amalgamated Bank's portfolio value fell 4.1% quarter-over-quarter to $11.7B.

Based on Amalgamated Bank's 13F filing for Q1 2025, filed 25 Apr 2025.